血浊理论在肺结节治疗中的应用OA
Application of"Blood Turbidity"Theory in the Treatment of Pulmonary Nodules
血浊理论在肺结节辨证治疗中具有重要意义.血浊状态是中医对肺结节微环境的独特诠释.本文基于血浊理论,结合肺结节的动态演变规律,深入剖析肺结节的证治.提出"浊血伤络"是肺结节发生发展的核心病机,指出浊血滞络是肺结节发生的病理基础,浊血损络是肺结节进展的病理关键,浊毒闭络是肺结节癌变的前提条件.因此,治疗时主张从"浊血伤络"角度,以清化血浊、恢复络脉功能为总则,辨证与辨阶段相结合,以解郁燮气、扶阳抑阴、化痰行瘀解毒与宣络、荣络、开络之法相结合,为肺结节的治疗提供新思路.
The theory of blood turbidity holds great significance in the syndrome differentiation and treatment of pulmonary nodules(PNs).The state of blood turbidity is a unique interpretation by traditional Chinese medicine of the microenvironment of PNs.Based on the theory of blood turbidity and combined with the dynamic evolution law of PNs,this article conducts an in-depth analysis of the syndrome differentiation and treatment of PNs.It is proposed that"the injury of collaterals by turbid blood"is the core pathogenesis of the occurrence and development of PNs.It is pointed out that the stagnation in collaterals is the pathological basis for the occurrence of PNs.The damage of collaterals by turbid blood is the pathological key to the progression of PNs.The blockage of collaterals by turbid toxin is the premise for the canceration of PNs.Therefore,in the treatment,it is advocated to start from the perspective of"the injury of collaterals by turbid blood",with the general principle of clearing and resolving blood turbidity and restoring the function of collaterals.Combining syndrome differentiation with stage differentiation,integrating the methods of relieving depression and regulating qi,assisting yang and restraining yin,resolving phlegm,promoting blood circulation,removing blood stasis,detoxifying,dredging collaterals,nourishing collaterals,and opening collaterals,which provides ideas for the treatment of PNs.
葛馨月;胡越;王林枫;刘瑞
中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053中国中医科学院广安门医院,北京 100053
医药卫生
肺结节血浊浊血伤络肺癌结癌转化
Pulmonary nodulesBlood-turbidityTurbid blood damaging collateralsLung cancerNodule-cancer transformation
《中医药学报》 2026 (7)
1-4,4
首都卫生发展专项(2024-2-4153)国家自然科学基金面上项目(82274609)中央高水平中医医院临床研究和成果转化能力提升项目——临床科研一体化人才专项青年拔尖人才培育项目(HLCMHPP2023101)中国中医科学院科技创新工程项目资助(CI2021A01810,CI2021B009)中国中医科学院优秀青年科技人才(创新类)培养专项(ZZ13-YQ-023)国家中医药管理局中医药创新团队及人才支持计划项目(ZYYCXTD-C-202205)
评论